Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

    • Laminar Medica Ltd

    Laminar Medica specialises in the design, test, manufacture and qualification of insulated shipping systems, used by the pharmaceutical and biotech industries globally. These systems protect vaccines, drugs, blood and associated medical products from extremes of temperature during transportation.

    This is a FREE LISTING on PMHUB

    Below are full profiles from other companies in related areas

    No items found

    Company Details

    Laminar Medica Ltd
    Unit 4, Tring Industrial Estate Icknield Way, Tring, Hertfordshire, HP23 4JX, United Kingdom
    +44 (0)1442 828664
    Contact Laminar Medica Ltd
    Website

     Latest Content from PMHub 

    Genesis Research Group RWD / HTA / regulatory / ECA webinar on 15 Feb: reserve your place!

    Press Releases | January 17, 2024 | Genesis Research Group

    On 15 February 2024, Carole Longson and Allie Sosinsky of Genesis Research Group, a leading global provider of tech-enabled real-world evidence, market access, and HEOR solutions, will present a webinar...

    Clinical trials explained: Why iconography matters…

    Press Releases | January 17, 2024 | Cuttsy + Cuttsy

    Icons serve as a useful form of alternative communication. We spend a lot of time developing icons for healthcare communications. Find out how we use iconography to elevate clinical trial...

    Bringing omnichannel to medical affairs: what do you need to know?

    White Papers and Resources | January 16, 2024 | Amiculum

    By Frank Fisher

    Trends in Virtual Collaboration

    White Papers and Resources | January 15, 2024 | Impetus Digital

    Join us for a look at the top-5 emerging virtual collaboration trends...

    Unlock possibilities: A Medical Affairs strategy fit for the future

    White Papers and Resources | January 15, 2024 | OPEN Health

    Explore the key areas to include in a Medical Affairs strategy and plan that is fit for the future in our latest whitepaper.

    Why Words Matter: Person-first language in the age of identity

    White Papers and Resources | January 12, 2024 | Mednet

    We take a look at why the words we use in medcomms matter and examine the use of patient-first language

    Advancing digital engagement in pharma and healthcare: 2024 focus areas

    Press Releases | January 12, 2024 | Graphite Digital

    6 areas for pharma and healthcare organisations to focus efforts in 2024 to drive better digital engagement amongst patients, HCPs and other users

    Advisor Questions on Potential Data or Knowledge Gaps

    Videos and Podcasts | January 11, 2024 | Impetus Digital

    As part of our top 10 most important advisor questions that every brand team should keep in mind when designing virtual advisory board touchpoints, here's another one to keep in...

    On a journey to diverse, inclusive, and more efficient rare disease trials

    White Papers and Resources | January 5, 2024 | Impetus Digital

    Although orphan drugs represent a sizeable portion of new drug approvals, most rare diseases still lack effective treatment. Even more so than for other conditions, rare disease management contains large care...

    Cuttsy+Cuttsy appoints Harriet Karia as Managing Director

    Press Releases | January 4, 2024 | Cuttsy + Cuttsy

    Cuttsy+Cuttsy is pleased to announce the appointment of Harriet Karia as its first Managing Director.